Cabot stock moves and recent performance snapshot

Cabot (CBT) has drawn fresh attention after recent share price moves, with the stock last closing at $78.93. Investors are weighing this level against the company’s current performance metrics and fundamentals.

The recent 1-day share price return of 4.06% and year-to-date share price return of 17.72% suggest momentum has been building, while the 1-year total shareholder return of 11.62% points to steadier progress over a longer horizon.

If Cabot’s recent move has you reassessing your watchlist, this can be a good moment to broaden your search and check out 19 top founder-led companies

With Cabot trading at $78.93, close to an analyst price target of $77.80 but at an estimated intrinsic discount near 22%, the key question is whether the stock remains undervalued or whether the market is already pricing in future growth.

Price-to-earnings of 13.5x: Is it justified?

Cabot’s current valuation appears inexpensive compared to peers, with a P/E of 13.5x versus 29.3x for the US Chemicals industry and 21.8x for its peer group.

The P/E ratio indicates how much investors are paying today for each dollar of current earnings, which is particularly relevant for a profitable, established chemicals business. With Cabot reporting revenue of $3,607 million and net income of $306 million, the earnings base is meaningful, so a lower P/E can indicate that the market is pricing those earnings more conservatively than for sector peers.

In that context, a P/E that sits well below both the industry and peer averages suggests the market is currently placing a discount on Cabot’s earnings profile rather than paying a premium for it.

CBT appears to offer relatively good value based on its Price-To-Earnings Ratio (13.5x) compared to the US Chemicals industry average (29.3x) and the peer average (21.8x), which is a notable relative gap.

Result: Preferred multiple of Price-to-Earnings of 13.5x (UNDERVALUED)

However, this setup can be challenged if chemicals demand softens across key regions or if input and energy costs squeeze Cabot’s $306 million earnings base.

Another view on value: cash flows tell a similar story

Price-based ratios are only one lens. Our DCF model, which estimates the present value of Cabot's future cash flows, points to a fair value of about $101.19 per share versus the current $78.93. That indicates the stock is trading at a material discount. Which signal would you lean on?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Cabot for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals or emerging opportunity? With both risks and rewards on the table, act quickly by reviewing the data yourself and weighing 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

Do not stop with a single stock. Broaden your opportunity set now and use focused stock lists to spot ideas that fit your style before others move first.

• Target potential upside in quality companies trading below estimated value by scanning 51 high quality undervalued stocks before prices fully reflect their fundamentals.
• Strengthen your income stream by reviewing 13 dividend fortresses that offer higher yields with an emphasis on resilience and consistency.
• Protect your portfolio on the downside by filtering for 72 resilient stocks with low risk scores so you are not caught off guard when conditions change.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.